| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.15 | 0.4 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |